Suppr超能文献

患者对参与临床试验的态度。

Patients' attitudes to participation in clinical trials.

作者信息

Bevan E G, Chee L C, McGhee S M, McInnes G T

机构信息

University Department of Medicine and Therapeutics, Gardiner Institute, Western Infirmary, Glasgow.

出版信息

Br J Clin Pharmacol. 1993 Feb;35(2):204-7.

Abstract
  1. In order to assess attitudes of patients to participation in therapeutic trials 197 patients underwent structured interviews conducted by a single observer. Of these patients 66 were previous or current participants in clinical trials (group A), 12 had declined participation in a trial (group B), and 119 had never been invited to participate in research (group C). 2. In group A, 62% stated their motivation for participation was to help others and 39% to improve their own treatment, but in 38% participation was to comply with the doctor's request. Two-thirds of group C patients would or might participate in a future hypothetical trial; of these more than half (57%) would do so to help others, and 42% to improve their own treatment. 3. Of the 12 patients who had declined entry into a study (group B) three did not want to alter their current therapy, three had insufficient time to participate in the particular trial, and in three cases relatives objected to their participation. Group C patients who stated they would not participate in trials gave being too ill (22%), not wanting to change treatment (22%), and fear of side-effects (17%) as the commonest reasons for declining. 4. In group A, 83% felt they had adequate time to consider their participation. Nearly two-thirds of patients (60%) would have liked written information to retain for reference, whereas only 38% were provided with information in this form. Over half of these patients (54%) disliked no aspect of the study in which they participated. Venepuncture and other uncomfortable procedures were least popular.(ABSTRACT TRUNCATED AT 250 WORDS)
摘要
  1. 为评估患者对参与治疗性试验的态度,由一名观察者对197名患者进行了结构化访谈。在这些患者中,66名曾是或目前是临床试验的参与者(A组),12名拒绝参与试验(B组),119名从未被邀请参与研究(C组)。2. 在A组中,62%的人表示参与的动机是帮助他人,39%是为了改善自身治疗,但38%的人参与是为了遵从医生的要求。三分之二的C组患者愿意或可能参与未来假设的试验;其中一半以上(57%)这样做是为了帮助他人,42%是为了改善自身治疗。3. 在12名拒绝参与研究的患者(B组)中,3人不想改变当前治疗,3人没有足够时间参与特定试验,3例是亲属反对他们参与。表示不会参与试验的C组患者给出的最常见拒绝理由是病情太重(22%)、不想改变治疗(22%)以及害怕副作用(17%)。4. 在A组中,83%的人觉得他们有足够时间考虑参与。近三分之二的患者(60%)希望得到书面信息以供留存参考,而只有38%的人得到了这种形式的信息。这些患者中超过一半(54%)对他们参与的研究没有任何不满。静脉穿刺和其他不舒服的操作最不受欢迎。(摘要截选至250词)

相似文献

6
[Addiction and brief-systemic therapy: working with compulsion].《成瘾与短期系统治疗:应对强迫行为》
Encephale. 2009 Jun;35(3):214-9. doi: 10.1016/j.encep.2008.06.002. Epub 2008 Aug 26.

引用本文的文献

1
Blood microsampling technologies: Innovations and applications in 2022.血液微量采样技术:2022年的创新与应用
Anal Sci Adv. 2023 May 18;4(5-6):154-180. doi: 10.1002/ansa.202300011. eCollection 2023 Jul.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验